FDA’s Lab-Developed Test Rule Vacated, Oversight Gap Persists
A court vacated the FDA’s 2024 rule to regulate lab-developed genetic tests, leaving oversight of mo...
By PROMPT Science Advisory BoardRead more
1 article
FDA/CMS, insurance-coverage, and lab-oversight changes affecting genetic testing.